CLASSIC HODGKIN LYMPHOMA
Clinical trials for CLASSIC HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSIC HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood test may allow safer, lighter chemo for hodgkin lymphoma patients
Disease control Recruiting nowThis study is for people with advanced Hodgkin lymphoma (stage 3 or 4) who have not yet had treatment. Researchers are testing whether a blood test that measures tumor DNA can help decide if a person can safely receive fewer chemotherapy cycles than usual. The goal is to reduce s…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for frail hodgkin patients: immunotherapy-chemo combo shows promise
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug pembrolizumab to a gentler chemotherapy regimen can safely treat frail patients newly diagnosed with classical Hodgkin lymphoma who cannot receive standard strong chemo. About 23 participants will receive the combination and …
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Can a simple blood test predict heart trouble in childhood cancer survivors?
Knowledge-focused Recruiting nowThis study looks at how certain blood cell changes (called clonal hematopoiesis) after Hodgkin lymphoma treatment might be linked to later heart problems. Researchers will test blood samples from 190 survivors who received chemotherapy as children or young adults. The goal is to …
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC